4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-23-013006
Chief Technology Officer sold 2,302 shares at $25.97 ($59,790)
- Chief Technology Officer acquired 37,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
HANLY ANN M. · Chief Technology Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-22 | Grant or award : show line 1 in the form | +37,500 | 119,505 | D | ||
| 2023-02-23 | Sale : show line 2 in the form | −2,302 | $25.97 | $59,790 | 117,203 | D |
| Open-market sales · 2,302 sh · avg $25.97 · $59,790 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-22 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +55,000 | 55,000 | D |
Loading xslF345X03/doc4.xml…